Virem R (Darunavir/Ritonavir)
| Active Ingredient | Darunavir/Ritonavir |
|---|---|
| Indication: | HIV infection |
| Manufacturer: | Emcure Pharmaceuticals Ltd. |
| Packaging | 60 Tablets in bottle |
| Strength | 700mg |
| Delivery Time | 6 To 15 days |
Virem R is a fixed-dose antiretroviral combination containing Darunavir and Ritonavir, both belonging to the protease inhibitor (PI) class. It is used in the treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (cART).
Darunavir blocks the HIV protease enzyme, preventing the virus from maturing and multiplying.
Ritonavir, at a low dose, acts as a booster, enhancing Darunavir’s effectiveness by increasing its concentration in the bloodstream.
When used with other HIV medications, Virem R helps achieve long-term viral suppression, improves CD4+ T-cell counts, and delays the progression of HIV.








There are no reviews yet.